EX-99.1 2 ea029493501ex99-1.htm AUDITED BALANCE SHEET Exhibit 99.1 JAB ACQUISITION CORP I INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of JAB Acquisition Corp I: Report of Independent Registered Public Accounting Firm (PCAOB ID#206) F-2 Balance Sheet as of June 11, 2026 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors of JAB Acquisition Corp I Opinion on the Financial Statement We have audited the accompanying balance sheet of JAB Acquisition Corp I (the “Company”) as of June 11, 2026, and the related notes (collectively referred to as the “financial statement”). In our opinion, the financial statement presents fairly, in all material respects, the financial position of the Company as of June 11, 2026, in conformity with accounting principles generally accepted in the United States of America. Going Concern Matter The accompanying financial statement has been prepared assuming that …
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
JAB Acquisition Corp I
Other Events
Item 8.01. Other Events. As previously disclosed, on June 11, 2026 (the “Closing”), JAB Acquisition Corp I (the “Company”) consummated its initial public offering (“IPO”), which consisted of 17,250,000 units, including 2,250,000 units (the “Units”) issued and sold pursuant to the exercise of the underwriters’ over-allotment option.…
Company context
JAB Acquisition Corp I is a blank-check company incorporated and registered in the Cayman Islands as an exempted company with limited liability for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Current securities
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item
8.01. Other Events.
As
previously disclosed, on June 11, 2026 (the “Closing”), JAB Acquisition Corp I (the “Company”) consummated
its initial public offering (“IPO”), which consisted of 17,250,000 units, including 2,250,000 units (the “Units”)
issued and sold pursuant to the exercise of the underwriters’ over-allotment option. Each Unit consists of one Class A ordinary
share, $0.0001 par value (“Class A Ordinary Share”) one redeemable warrant of the Company (each, a “Warrant”),
with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share (subject to adjustment),
and one right of the Company (each, a “Right”) to receive one-fourth (¼th) of one Class A ordinary share upon the
consummation of an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds
of $172,500,000.
As
previously disclosed, simultaneously with the closing of the IPO, the Company consummated a private placement (the “Private Placement”)
of an aggregate of 260,000 units (the “Private Units”) to the Sponsor, at a price of $10.00 per Private Unit, generating
total proceeds of $2,600,000. Each Private Unit consists of one Class A Ordinary Share, one redeemable warrant, with each whole warrant
entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share (subject to adjustment), and one right to receive
one-fourth (¼ th ) of one Class A ordinary share upon the consummation of an initial business combination. In connection
with the exercise of the over-allotment option, no additional Private Units were sold and no incremental underwriting expense was incurred.
An
audited balance sheet reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement is included as Exhibit
99.1 to this Current Report on Form 8-K.